S2Medical AB Cash Flow-to-Debt Ratio
S2Medical AB cash flow-to-debt ratio. S2Medical AB (S2M) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of Skr169.00K could theoretically repay 0% of its total liabilities (Skr6.84 Million) in one year. Check S2Medical AB (S2M) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of S2Medical AB (2016–2025)
Cash flow-to-debt ratio of S2Medical AB from 2016 to 2025. Historical debt coverage capacity for S2Medical AB across 10 annual periods. Check S2M cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
S2Medical AB Cash Flow-to-Debt Ratio by Year (2016–2025)
S2Medical AB cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for S2Medical AB. For the full cash flow conversion analysis, see S2M operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | Skr675.00K | Skr7.03 Million | ▼ -88.0% |
| 2024 | 0.80x | Skr5.03 Million | Skr6.29 Million | ▲ +195.7% |
| 2023 | -0.84x | Skr-16.52 Million | Skr19.75 Million | ▲ +45.8% |
| 2022 | -1.54x | Skr-28.13 Million | Skr18.22 Million | ▼ -17.7% |
| 2021 | -1.31x | Skr-19.67 Million | Skr15.00 Million | ▲ +12.8% |
| 2020 | -1.50x | Skr-12.75 Million | Skr8.48 Million | ▲ +50.8% |
| 2019 | -3.05x | Skr-17.10 Million | Skr5.60 Million | ▼ -32.5% |
| 2018 | -2.31x | Skr-12.75 Million | Skr5.53 Million | ▼ -49.8% |
| 2017 | -1.54x | Skr-5.85 Million | Skr3.80 Million | ▼ -86.6% |
| 2016 | -0.82x | Skr-3.03 Million | Skr3.67 Million | — |